Medicine and Dentistry
Neoplasm
100%
Chemoradiotherapy
94%
Disease
79%
Colorectal Cancer
76%
Malignant Neoplasm
69%
Rectum Cancer
59%
Stomach Cancer
56%
Overall Survival
55%
Esophageal Cancer
52%
Recurrent Disease
48%
Radiation Therapy
40%
Prognostic Factor
38%
Adenocarcinoma
37%
Colon Cancer
35%
Surgery
34%
Merkel Cell Carcinoma
33%
Positron Emission Tomography-Computed Tomography
33%
Retrospective Study
30%
Breast Cancer
30%
Metastatic Carcinoma
28%
Disease Free Survival
28%
Gastrointestinal Tract
27%
Neoadjuvant Therapy
27%
Fluorouracil
27%
Capecitabine
24%
Cancer
23%
Cisplatin
22%
Neoadjuvant Chemotherapy
22%
Primary Tumor
22%
Multivariate Analysis
22%
Biological Marker
22%
Kaposi Sarcoma
22%
Oxaliplatin
21%
Quality of Life
21%
Computer Assisted Tomography
19%
Small-Cell Carcinoma
19%
Progression Free Survival
19%
Immunohistochemistry
18%
Survival Rate
18%
Gastroesophageal Junction
17%
Cancer Surgery
17%
Colon
16%
Metastatic Colorectal Cancer
16%
Liver Metastasis
16%
Mismatch Repair Protein
16%
Laryngeal Cancer
16%
Placebo
16%
Pembrolizumab
16%
Symptom
16%
Nodular Melanoma
15%
Keyphrases
Colorectal Cancer
96%
Israel
68%
5-fluorouracil (5-FU)
64%
Overall Survival
54%
Cisplatin
53%
Tumor
51%
Esophageal Cancer
49%
Gastric Cancer
44%
Chemotherapy
44%
Disease-free Survival
41%
Neoadjuvant Chemoradiotherapy (nCRT)
39%
Phase II Trial
35%
Prognostic Factors
31%
Merkel Cell Carcinoma
30%
Capecitabine
30%
Neoadjuvant Therapy
29%
Breast Cancer
28%
Positron Emission Tomography-computed Tomography (PET-CT)
27%
Gastrointestinal Tract
27%
Bevacizumab
27%
High Risk
26%
Concurrent Chemoradiotherapy
25%
Leucovorin
24%
Medical Center
24%
Multivariate Analysis
24%
Radiotherapy
23%
Preoperative Chemoradiation
23%
Advanced Esophageal Cancer
23%
Oxaliplatin
23%
Israeli
22%
Colon Cancer
22%
Kaposi Sarcoma
22%
Colorectal Liver Metastases
22%
Oncologists
22%
Metastatic Colorectal Cancer (mCRC)
22%
Stage II Colon Cancer
22%
Malignancy
22%
Pathological Complete Response
22%
Cancer Patients
21%
Radiation Therapy
20%
Adenocarcinoma
20%
Locally Advanced Rectal Cancer
20%
Adjuvant Chemotherapy
20%
Young Patients
20%
5-year Survival
20%
Continuous Infusion
19%
Neoadjuvant Chemotherapy
19%
Small Cell Carcinoma
19%
Treatment Options
19%
Median Overall Survival
18%
Pharmacology, Toxicology and Pharmaceutical Science
Chemoradiation Therapy
87%
Chemotherapy
83%
Neoplasm
72%
Stomach Cancer
72%
Fluorouracil
64%
Disease
61%
Cisplatin
58%
Overall Survival
54%
Malignant Neoplasm
52%
Colorectal Cancer
49%
Recurrent Disease
46%
Esophagus Cancer
43%
Rectum Cancer
42%
Colon Cancer
39%
Capecitabine
30%
Merkel Cell Carcinoma
27%
Bevacizumab
27%
Disease Free Survival
27%
Adenocarcinoma
27%
Oxaliplatin
27%
Folinic Acid
25%
Breast Cancer
23%
Metastatic Colorectal Cancer
22%
Survival Rate
21%
Primary Tumor
18%
Progression Free Survival
18%
Melanoma
18%
Symptom
17%
Placebo
17%
Docetaxel
16%
Pembrolizumab
16%
Adverse Event
15%
Squamous Cell Carcinoma
15%
Metastasis
13%
Retrospective Study
13%
Neutropenia
13%
Irinotecan
12%
Epidermal Growth Factor Receptor
11%
Cetuximab
11%
microRNA
11%
Liver Metastasis
11%
Paclitaxel
11%
Diarrhea
10%
Fluoropyrimidine
9%
Larynx Cancer
9%
Cohort Study
9%
Clinical Trial
8%
Maximum Tolerated Dose
7%
Tolerability
7%
Combination Therapy
7%